HCPCS Level II · 1,112 active codes
J codes: Drugs administered other than oral method
- J0013Esketamine, nasal spray, 1 mg
- J0014Cocaine hydrochloride nasal solution (goprelto), 1 mg
- J0120Injection, tetracycline, up to 250 mg
- J0121Injection, omadacycline, 1 mg
- J0122Injection, eravacycline, 1 mg
- J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130Injection abciximab, 10 mg
- J0131Injection, acetaminophen, not otherwise specified,10 mg
- J0132Injection, acetylcysteine, 100 mg
- J0133Injection, acyclovir, 5 mg
- J0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
- J0135Injection, adalimumab, 20 mg
- J0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
- J0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
- J0138Injection, acetaminophen 10 mg and ibuprofen 3 mg
- J0139Injection, adalimumab, 1 mg
- J0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
- J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
- J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
- J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
- J0163Injection, epinephrine in sodium chloride (endo), 0.1 mg
- J0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg
- J0165Injection, epinephrine, not otherwise specified, 0.1 mg
- J0166Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
- J0167Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
- J0168Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
- J0169Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
- J0171Injection, adrenalin, epinephrine, 0.1 mg
- J0172Injection, aducanumab-avwa, 2 mg
- J0173Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg
- J0174Lecanemab-irmb, for intravenous injection, 1 mg
- J0175Injection, donanemab-azbt, 2 mg
- J0177Injection, aflibercept hd, 1 mg
- J0178Injection, aflibercept, 1 mg
- J0179Injection, brolucizumab-dbll, 1 mg
- J0180Injection, agalsidase beta, 1 mg
- J0184Injection, amisulpride, 1 mg
- J0185Injection, aprepitant, 1 mg
- J0190Injection, biperiden lactate, per 5 mg
- J0200Injection, alatrofloxacin mesylate, 100 mg
- J0202Injection, alemtuzumab, 1 mg
- J0205Injection, alglucerase, per 10 units
- J0206Injection, allopurinol sodium, 1 mg
- J0207Injection, amifostine, 500 mg
- J0208Injection, sodium thiosulfate (pedmark), 100 mg
- J0209Injection, sodium thiosulfate (hope), 100 mg
- J0210Injection, methyldopate hcl, up to 250 mg
- J0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215Injection, alefacept, 0.5 mg
- J0216Injection, alfentanil hydrochloride, 500 micrograms
- J0217Injection, velmanase alfa-tycv, 1 mg
- J0218Injection, olipudase alfa-rpcp, 1 mg
- J0219Injection, avalglucosidase alfa-ngpt, 4 mg
- J0220Injection, alglucosidase alfa, 10 mg, not otherwise specified
- J0221Injection, alglucosidase alfa, (lumizyme), 10 mg
- J0222Injection, patisiran, 0.1 mg
- J0223Injection, givosiran, 0.5 mg
- J0224Injection, lumasiran, 0.5 mg
- J0225Injection, vutrisiran, 1 mg
- J0248Injection, remdesivir, 1 mg
- J0256Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
- J0257Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
- J0270Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0275Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0278Injection, amikacin sulfate, 100 mg
- J0280Injection, aminophyllin, up to 250 mg
- J0281Injection, aminocaproic acid, 1 gram
- J0282Injection, amiodarone hydrochloride, 30 mg
- J0283Injection, amiodarone hydrochloride (nexterone), 30 mg
- J0285Injection, amphotericin b, 50 mg
- J0287Injection, amphotericin b lipid complex, 10 mg
- J0288Injection, amphotericin b cholesteryl sulfate complex, 10 mg
- J0289Injection, amphotericin b liposome, 10 mg
- J0290Injection, ampicillin sodium, 500 mg
- J0291Injection, plazomicin, 5 mg
- J0295Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
- J0300Injection, amobarbital, up to 125 mg
- J0330Injection, succinylcholine chloride, up to 20 mg
- J0348Injection, anidulafungin, 1 mg
- J0349Injection, rezafungin, 1 mg
- J0350Injection, anistreplase, per 30 units
- J0360Injection, hydralazine hcl, up to 20 mg
- J0364Injection, apomorphine hydrochloride, 1 mg
- J0365Injection, aprotonin, 10,000 kiu
- J0380Injection, metaraminol bitartrate, per 10 mg
- J0390Injection, chloroquine hydrochloride, up to 250 mg
- J0391Injection, artesunate, 1 mg
- J0395Injection, arbutamine hcl, 1 mg
- J0400Injection, aripiprazole, intramuscular, 0.25 mg
- J0401Injection, aripiprazole (abilify maintena), 1 mg
- J0402Injection, aripiprazole (abilify asimtufii), 1 mg
- J0456Injection, azithromycin, 500 mg
- J0457Injection, aztreonam, 100 mg
- J0458Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)
- J0461Injection, atropine sulfate, 0.01 mg
- J0462Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
- J0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
- J0470Injection, dimercaprol, per 100 mg
- J0475Injection, baclofen, 10 mg
- J0476Injection, baclofen, 50 mcg for intrathecal trial
- J0480Injection, basiliximab, 20 mg
- J0485Injection, belatacept, 1 mg
- J0490Injection, belimumab, 10 mg
- J0491Injection, anifrolumab-fnia, 1 mg
- J0500Injection, dicyclomine hcl, up to 20 mg
- J0515Injection, benztropine mesylate, per 1 mg
- J0517Injection, benralizumab, 1 mg
- J0520Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
- J0525Injection, cefotetan disodium, 10 mg
- J0528Injection, fosfomycin disodium, 20 mg
- J0558Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
- J0561Injection, penicillin g benzathine, 100,000 units
- J0565Injection, bezlotoxumab, 10 mg
- J0567Injection, cerliponase alfa, 1 mg
- J0570Buprenorphine implant, 74.2 mg
- J0571Buprenorphine, oral, 1 mg
- J0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
- J0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
- J0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
- J0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
- J0576Injection, buprenorphine extended-release (brixadi), 1 mg
- J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
- J0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
- J0582Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
- J0583Injection, bivalirudin, 1 mg
- J0584Injection, burosumab-twza 1 mg
- J0585Injection, onabotulinumtoxina, 1 unit
- J0586Injection, abobotulinumtoxina, 5 units
- J0587Injection, rimabotulinumtoxinb, 100 units
- J0588Injection, incobotulinumtoxin a, 1 unit
- J0589Injection, daxibotulinumtoxina-lanm, 1 unit
- J0591Injection, deoxycholic acid, 1 mg
- J0592Injection, buprenorphine hydrochloride, 0.1 mg
- J0593Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
- J0594injection, busulfan, 1 mg
- J0595Injection, butorphanol tartrate, 1 mg
- J0596Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
- J0597Injection, c-1 esterase inhibitor (human), berinert, 10 units
- J0598Injection, c-1 esterase inhibitor (human), cinryze, 10 units
- J0599Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
- J0600Injection, edetate calcium disodium, up to 1000 mg
- J0601Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0602Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
- J0603Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0604Cinacalcet, oral, 1 mg, (for esrd on dialysis)
- J0605Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
- J0606Injection, etelcalcetide, 0.1 mg
- J0607Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
- J0608Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
- J0609Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
- J0610Injection, calcium gluconate (fresenius kabi), per 10 ml
- J0611Injection, calcium gluconate (wg critical care), per 10 ml
- J0612Injection, calcium gluconate, not otherwise specified, 10 mg
- J0613Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
- J0614Injection, treosulfan, 50 mg
- J0615Calcium acetate, oral, 23 mg (for esrd on dialysis)
- J0616Injection, metoprolol tartrate, 1 mg
- J0618Injection, calcium chloride, 2 mg
- J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml
- J0630Injection, calcitonin salmon, up to 400 units
- J0636Injection, calcitriol, 0.1 mcg
- J0637Injection, caspofungin acetate, 5 mg
- J0638Injection, canakinumab, 1 mg
- J0640Injection, leucovorin calcium, per 50 mg
- J0641Injection, levoleucovorin, not otherwise specified, 0.5 mg
- J0642Injection, levoleucovorin (khapzory), 0.5 mg
- J0643Injection, leucovorin calcium, not otherwise specified, 1 mg
- J0644Injection, leucovorin calcium (avyxa), 1 mg
- J0650Injection, levothyroxine sodium, not otherwise specified, 10 mcg
- J0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
- J0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
- J0654Injection, liothyronine, 1 mcg
- J0665Injection, bupivicaine, not otherwise specified, 0.5 mg
- J0666Injection, bupivacaine liposome, 1 mg
- J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
- J0670Injection, mepivacaine hydrochloride, per 10 ml
- J0675Injection, carboprost tromethamine, 0.1 mg
- J0681Injection, ceftobiprole medocaril sodium, 3 mg
- J0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
- J0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
- J0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
- J0690Injection, cefazolin sodium, 500 mg
- J0691Injection, lefamulin, 1 mg
- J0692Injection, cefepime hydrochloride, 500 mg
- J0693Injection, cefiderocol, 5 mg
- J0694Injection, cefoxitin sodium, 1 gm
- J0695Injection, ceftolozane 50 mg and tazobactam 25 mg
- J0696Injection, ceftriaxone sodium, per 250 mg
- J0697Injection, sterile cefuroxime sodium, per 750 mg
- J0698Injection, cefotaxime sodium, per gm
- J0699Injection, cefiderocol, 10 mg
- J0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
- J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
- J0703Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
- J0706Injection, caffeine citrate, 5 mg
- J0710Injection, cephapirin sodium, up to 1 gm
- J0712Injection, ceftaroline fosamil, 10 mg
- J0713Injection, ceftazidime, per 500 mg
- J0714Injection, ceftazidime and avibactam, 0.5 g/0.125 g
- J0715Injection, ceftizoxime sodium, per 500 mg
- J0716Injection, centruroides immune f(ab)2, up to 120 milligrams
- J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0720Injection, chloramphenicol sodium succinate, up to 1 gm
- J0725Injection, chorionic gonadotropin, per 1,000 usp units
- J0735Injection, clonidine hydrochloride, 1 mg
- J0736Injection, clindamycin phosphate, 300 mg
- J0737Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
- J0738Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0739Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0740Injection, cidofovir, 375 mg
- J0741Injection, cabotegravir and rilpivirine, 2mg/3mg
- J0742Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
- J0743Injection, cilastatin sodium; imipenem, per 250 mg
- J0744Injection, ciprofloxacin for intravenous infusion, 200 mg
- J0745Injection, codeine phosphate, per 30 mg
- J0750Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0751Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0752Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0759Injection, clevidipine butyrate, 1 mg
- J0760Injection, colchicine, per 1 mg
- J0770Injection, colistimethate sodium, up to 150 mg
- J0775Injection, collagenase, clostridium histolyticum, 0.01 mg
- J0780Injection, prochlorperazine, up to 10 mg
- J0791Injection, crizanlizumab-tmca, 5 mg
- J0795Injection, corticorelin ovine triflutate, 1 microgram
- J0799Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
- J0800Injection, corticotropin, up to 40 units
- J0801Injection, corticotropin (acthar gel), up to 40 units
- J0802Injection, corticotropin (ani), up to 40 units
- J0833Injection, cosyntropin, not otherwise specified, 0.25 mg
- J0834Injection, cosyntropin, 0.25 mg
- J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870Injection, imetelstat, 1 mg
- J0871Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
- J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0873Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
- J0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
- J0875Injection, dalbavancin, 5 mg
- J0877Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
- J0878Injection, daptomycin, 1 mg
- J0879Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
- J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)
- J0882Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
- J0883Injection, argatroban, 1 mg (for non-esrd use)
- J0884Injection, argatroban, 1 mg (for esrd on dialysis)
- J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
- J0886Injection, epoetin alfa, 1000 units (for esrd on dialysis)
- J0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)
- J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894Injection, decitabine, 1 mg
- J0895Injection, deferoxamine mesylate, 500 mg
- J0896Injection, luspatercept-aamt, 0.25 mg
- J0897Injection, denosumab, 1 mg
- J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0899Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0900Injection, testosterone enanthate and estradiol valerate, up to 1 cc
- J0901Vadadustat, oral, 1 mg (for esrd on dialysis)
- J0911Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
- J0945Injection, brompheniramine maleate, per 10 mg
- J1000Injection, depo-estradiol cypionate, up to 5 mg
- J1010Injection, methylprednisolone acetate, 1 mg
- J1020Injection, methylprednisolone acetate, 20 mg
- J1030Injection, methylprednisolone acetate, 40 mg
- J1040Injection, methylprednisolone acetate, 80 mg
- J1050Injection, medroxyprogesterone acetate, 1 mg
- J1060Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070Injection, testosterone cypionate, up to 100 mg
- J1071Injection, testosterone cypionate, 1 mg
- J1072Injection, testosterone cypionate (azmiro), 1 mg
- J1073Testosterone pellet, implant, 75 mg
- J1080Injection, testosterone cypionate, 1 cc, 200 mg
- J1094Injection, dexamethasone acetate, 1 mg
- J1095Injection, dexamethasone 9 percent, intraocular, 1 microgram
- J1096Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
- J1097Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
- J1098Articaine ophthalmic, 8% solution, 0.4 ml
- J1100Injection, dexamethasone sodium phosphate, 1 mg
- J1105Dexmedetomidine, oral, 1 mcg
- J1110Injection, dihydroergotamine mesylate, per 1 mg
- J1120Injection, acetazolamide sodium, up to 500 mg
- J1130Injection, diclofenac sodium, 0.5 mg
- J1160Injection, digoxin, up to 0.5 mg
- J1162Injection, digoxin immune fab (ovine), per vial
- J1163Injection, diltiazem hydrochloride, 0.5 mg
- J1164Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
- J1165Injection, phenytoin sodium, per 50 mg
- J1170Injection, hydromorphone, up to 4 mg
- J1171Injection, hydromorphone, 0.1 mg
- J1180Injection, dyphylline, up to 500 mg
- J1190Injection, dexrazoxane hydrochloride, per 250 mg
- J1200Injection, diphenhydramine hcl, up to 50 mg
- J1201Injection, cetirizine hydrochloride, 0.5 mg
- J1202Miglustat, oral, 65 mg
- J1203Injection, cipaglucosidase alfa-atga, 5 mg
- J1205Injection, chlorothiazide sodium, per 500 mg
- J1212Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
- J1230Injection, methadone hcl, up to 10 mg
- J1240Injection, dimenhydrinate, up to 50 mg
- J1245Injection, dipyridamole, per 10 mg
- J1250Injection, dobutamine hydrochloride, per 250 mg
- J1260Injection, dolasetron mesylate, 10 mg
- J1265Injection, dopamine hcl, 40 mg
- J1267Injection, doripenem, 10 mg
- J1270Injection, doxercalciferol, 1 mcg
- J1271Injection, doxycycline hyclate, 1 mg
- J1289Injection, narsoplimab-wuug, 1 mg
- J1290Injection, ecallantide, 1 mg
- J1299Injection, eculizumab, 2 mg
- J1300Injection, eculizumab, 10 mg
- J1301Injection, edaravone, 1 mg
- J1302Injection, sutimlimab-jome, 10 mg
- J1303Injection, ravulizumab-cwvz, 10 mg
- J1304Injection, tofersen, 1 mg
- J1305Injection, evinacumab-dgnb, 5mg
- J1306Injection, inclisiran, 1 mg
- J1307Injection, crovalimab-akkz, 10 mg
- J1308Injection, famotidine, 0.25 mg
- J1320Injection, amitriptyline hcl, up to 20 mg
- J1322Injection, elosulfase alfa, 1 mg
- J1323Injection, elranatamab-bcmm, 1 mg
- J1324Injection, enfuvirtide, 1 mg
- J1325Injection, epoprostenol, 0.5 mg
- J1326Injection, zolbetuximab-clzb, 2 mg
- J1327Injection, eptifibatide, 5 mg
- J1330Injection, ergonovine maleate, up to 0.2 mg
- J1335Injection, ertapenem sodium, 500 mg
- J1364Injection, erythromycin lactobionate, per 500 mg
- J1370Injection, esomeprazole sodium, 1 mg
- J1380Injection, estradiol valerate, up to 10 mg
- J1410Injection, estrogen conjugated, per 25 mg
- J1411Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1413Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
- J1414Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- J1426Injection, casimersen, 10 mg
- J1427Injection, viltolarsen, 10 mg
- J1428Injection, eteplirsen, 10 mg
- J1429Injection, golodirsen, 10 mg
- J1430Injection, ethanolamine oleate, 100 mg
- J1434Injection, fosaprepitant (focinvez), 1 mg
- J1435Injection, estrone, per 1 mg
- J1436Injection, etidronate disodium, per 300 mg
- J1437Injection, ferric derisomaltose, 10 mg
- J1438Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J1439Injection, ferric carboxymaltose, 1 mg
- J1440Fecal microbiota, live - jslm, 1 ml
- J1442Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
- J1443Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron
- J1444Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
- J1445Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron
- J1446Injection, tbo-filgrastim, 5 micrograms
- J1447Injection, tbo-filgrastim, 1 microgram
- J1448Injection, trilaciclib, 1mg
- J1449Injection, eflapegrastim-xnst, 0.1 mg
- J1450Injection fluconazole, 200 mg
- J1451Injection, fomepizole, 15 mg
- J1452Injection, fomivirsen sodium, intraocular, 1.65 mg
- J1453Injection, fosaprepitant, 1 mg
- J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- J1455Injection, foscarnet sodium, per 1000 mg
- J1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- J1457Injection, gallium nitrate, 1 mg
- J1458Injection, galsulfase, 1 mg
- J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1460Injection, gamma globulin, intramuscular, 1 cc
- J1551Injection, immune globulin (cutaquig), 100 mg
- J1552Injection, immune globulin (alyglo), 500 mg
- J1553Injection, immune globulin (yimmugo), 100 mg
- J1554Injection, immune globulin (asceniv), 500 mg
- J1555Injection, immune globulin (cuvitru), 100 mg
- J1556Injection, immune globulin (bivigam), 500 mg
- J1557Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558Injection, immune globulin (xembify), 100 mg
- J1559Injection, immune globulin (hizentra), 100 mg
- J1560Injection, gamma globulin, intramuscular, over 10 cc
- J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562Injection, immune globulin (vivaglobin), 100 mg
- J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
- J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1569Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
- J1570Injection, ganciclovir sodium, 500 mg
- J1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
- J1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
- J1574Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
- J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
- J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1577Injection, immune globulin (qivigy), 100 mg
- J1580Injection, garamycin, gentamicin, up to 80 mg
- J1590Injection, gatifloxacin, 10 mg
- J1595Injection, glatiramer acetate, 20 mg
- J1596Injection, glycopyrrolate, 0.1 mg
- J1597Injection, glycopyrrolate (glyrx-pf), 0.1 mg
- J1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
- J1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
- J1600Injection, gold sodium thiomalate, up to 50 mg
- J1602Injection, golimumab, 1 mg, for intravenous use
- J1610Injection, glucagon hydrochloride, per 1 mg
- J1611Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1612Injection, glucagon (gvoke), 0.01 mg
- J1620Injection, gonadorelin hydrochloride, per 100 mcg
- J1626Injection, granisetron hydrochloride, 100 mcg
- J1627Injection, granisetron, extended-release, 0.1 mg
- J1628Injection, guselkumab, 1 mg
- J1630Injection, haloperidol, up to 5 mg
- J1631Injection, haloperidol decanoate, per 50 mg
- J1632Injection, brexanolone, 1 mg
- J1640Injection, hemin, 1 mg
- J1642Injection, heparin sodium, (heparin lock flush), per 10 units
- J1643Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
- J1644Injection, heparin sodium, per 1000 units
- J1645Injection, dalteparin sodium, per 2500 iu
- J1650Injection, enoxaparin sodium, 10 mg
- J1652Injection, fondaparinux sodium, 0.5 mg
- J1655Injection, tinzaparin sodium, 1000 iu
- J1670Injection, tetanus immune globulin, human, up to 250 units
- J1675Injection, histrelin acetate, 10 micrograms
- J1700Injection, hydrocortisone acetate, up to 25 mg
- J1710Injection, hydrocortisone sodium phosphate, up to 50 mg
- J1720Injection, hydrocortisone sodium succinate, up to 100 mg
- J1725Injection, hydroxyprogesterone caproate, 1 mg
- J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730Injection, diazoxide, up to 300 mg
- J1736Injection, meloxicam (delova), 1 mg
- J1737Injection, meloxicam (azurity), 1 mg
- J1738Injection, meloxicam, 1 mg
- J1740Injection, ibandronate sodium, 1 mg
- J1741Injection, ibuprofen, 100 mg
- J1742Injection, ibutilide fumarate, 1 mg
- J1743Injection, idursulfase, 1 mg
- J1744Injection, icatibant, 1 mg
- J1745Injection, infliximab, excludes biosimilar, 10 mg
- J1746Injection, ibalizumab-uiyk, 10 mg
- J1747Injection, spesolimab-sbzo, 1 mg
- J1748Injection, infliximab-dyyb (zymfentra), 10 mg
- J1749Injection, iloprost, 0.1 mcg
- J1750Injection, iron dextran, 50 mg
- J1756Injection, iron sucrose, 1 mg
- J1757Injection, tividenofusp alfa-eknm, 1 mg
- J1786Injection, imiglucerase, 10 units
- J1790Injection, droperidol, up to 5 mg
- J1800Injection, propranolol hcl, up to 1 mg
- J1805Injection, esmolol hydrochloride, 10 mg
- J1806Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
- J1807Injection, ethacrynate sodium, 1 mg
- J1808Injection, folic acid, 0.1 mg
- J1809Injection, fosdenopterin, 0.1 mg
- J1810Injection, droperidol and fentanyl citrate, up to 2 ml ampule
- J1811Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
- J1812Insulin (fiasp), per 5 units
- J1813Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
- J1814Insulin (lyumjev), per 5 units
- J1815Injection, insulin, per 5 units
- J1817Insulin for administration through dme (i.e., insulin pump) per 50 units
- J1818Injection, pegzilarginase-nbln, 0.05 mg
- J1823Injection, inebilizumab-cdon, 1 mg
- J1826Injection, interferon beta-1a, 30 mcg
- J1830Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J1833Injection, isavuconazonium, 1 mg
- J1834Injection, isoniazid, 1 mg
- J1835Injection, itraconazole, 50 mg
- J1836Injection, metronidazole, 10 mg
- J1837Injection, posaconazole, 1 mg
- J1840Injection, kanamycin sulfate, up to 500 mg
- J1850Injection, kanamycin sulfate, up to 75 mg
- J1885Injection, ketorolac tromethamine, per 15 mg
- J1890Injection, cephalothin sodium, up to 1 gram
- J1920Injection, labetalol hydrochloride, 5 mg
- J1921Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
- J1930Injection, lanreotide, 1 mg
- J1931Injection, laronidase, 0.1 mg
- J1932Injection, lanreotide, (cipla), 1 mg
- J1938Injection, furosemide, 1 mg
- J1939Injection, bumetanide, 0.5 mg
- J1940Injection, furosemide, up to 20 mg
- J1941Injection, furosemide (furoscix), 20 mg
- J1942Injection, aripiprazole lauroxil, 1 mg
- J1943Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1945Injection, lepirudin, 50 mg
- J1946Injection, furosemide (lasix onyu), 1 mg
- J1947Injection, furosemide (furoscix), 1 mg
- J1950Injection, leuprolide acetate (for depot suspension), per 3.75 mg
- J1951Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
- J1952Leuprolide injectable, camcevi, 1 mg
- J1953Injection, levetiracetam, 10 mg
- J1954Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg
- J1955Injection, levocarnitine, per 1 gm
- J1956Injection, levofloxacin, 250 mg
- J1957Injection, levetiracetam, 5 mg
- J1958Injection, levetiracetam in sodium chloride, 5 mg
- J1960Injection, levorphanol tartrate, up to 2 mg
- J1961Injection, lenacapavir (only for use as hiv treatment), 1 mg
- J1980Injection, hyoscyamine sulfate, up to 0.25 mg
- J1990Injection, chlordiazepoxide hcl, up to 100 mg
- J2001Injection, lidocaine hcl for intravenous infusion, 10 mg
- J2002Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003Injection, lidocaine hydrochloride, 1 mg
- J2004Injection, lidocaine hcl with epinephrine, 1 mg
- J2010Injection, lincomycin hcl, up to 300 mg
- J2020Injection, linezolid, 200 mg
- J2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060Injection, lorazepam, 2 mg
- J2062Loxapine for inhalation, 1 mg
- J2150Injection, mannitol, 25% in 50 ml
- J2151Injection, mannitol, 250 mg
- J2170Injection, mecasermin, 1 mg
- J2175Injection, meperidine hydrochloride, per 100 mg
- J2180Injection, meperidine and promethazine hcl, up to 50 mg
- J2182Injection, mepolizumab, 1 mg
- J2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185Injection, meropenem, 100 mg
- J2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
- J2210Injection, methylergonovine maleate, up to 0.2 mg
- J2212Injection, methylnaltrexone, 0.1 mg
- J2246Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
- J2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
- J2248Injection, micafungin sodium, 1 mg
- J2249Injection, remimazolam, 1 mg
- J2250Injection, midazolam hydrochloride, per 1 mg
- J2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2252Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2253Injection, midazolam (seizalam), 1 mg
- J2260Injection, milrinone lactate, 5 mg
- J2265Injection, minocycline hydrochloride, 1 mg
- J2267Injection, mirikizumab-mrkz, 1 mg
- J2270Injection, morphine sulfate, up to 10 mg
- J2271Injection, morphine sulfate, 100mg
- J2272Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
- J2274Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- J2275Injection, morphine sulfate (preservative-free sterile solution), per 10 mg
- J2277Injection, motixafortide, 0.25 mg
- J2278Injection, ziconotide, 1 microgram
- J2280Injection, moxifloxacin, 100 mg
- J2281Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
- J2290Injection, nafcillin sodium, 20 mg
- J2291Injection, nafcillin sodium (baxter), 20 mg
- J2300Injection, nalbuphine hydrochloride, per 10 mg
- J2305Injection, nitroglycerin, 5 mg
- J2310Injection, naloxone hydrochloride, per 1 mg
- J2311Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315Injection, naltrexone, depot form, 1 mg
- J2320Injection, nandrolone decanoate, up to 50 mg
- J2323Injection, natalizumab, 1 mg
- J2325Injection, nesiritide, 0.1 mg
- J2326Injection, nusinersen, 0.1 mg
- J2327Injection, risankizumab-rzaa, intravenous, 1 mg
- J2329Injection, ublituximab-xiiy, 1mg
- J2350Injection, ocrelizumab, 1 mg
- J2351Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
- J2353Injection, octreotide, depot form for intramuscular injection, 1 mg
- J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
- J2355Injection, oprelvekin, 5 mg
- J2356Injection, tezepelumab-ekko, 1 mg
- J2357Injection, omalizumab, 5 mg
- J2358Injection, olanzapine, long-acting, 1 mg
- J2359Injection, olanzapine, 0.5 mg
- J2360Injection, orphenadrine citrate, up to 60 mg
- J2361Injection, depemokimab-ulaa, 1 mg
- J2370Injection, phenylephrine hcl, up to 1 ml
- J2371Injection, phenylephrine hydrochloride, 20 micrograms
- J2372Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
- J2373Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
- J2374Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml
- J2400Injection, chloroprocaine hydrochloride, per 30 ml
- J2401Injection, chloroprocaine hydrochloride, per 1 mg
- J2402Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404Injection, nicardipine, 0.1 mg
- J2405Injection, ondansetron hydrochloride, per 1 mg
- J2406Injection, oritavancin (kimyrsa), 10 mg
- J2407Injection, oritavancin (orbactiv), 10 mg
- J2410Injection, oxymorphone hcl, up to 1 mg
- J2425Injection, palifermin, 50 micrograms
- J2426Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428Injection, paliperidone palmitate extended release (erzofri), 1 mg
- J2430Injection, pamidronate disodium, per 30 mg
- J2440Injection, papaverine hcl, up to 60 mg
- J2460Injection, oxytetracycline hcl, up to 50 mg
- J2468Injection, palonosetron hydrochloride (posfrea), 25 micrograms
- J2469Injection, palonosetron hcl, 25 mcg
- J2470Injection, pantoprazole sodium, 40 mg
- J2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
- J2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg
- J2501Injection, paricalcitol, 1 mcg
- J2502Injection, pasireotide long acting, 1 mg
- J2503Injection, pegaptanib sodium, 0.3 mg
- J2504Injection, pegademase bovine, 25 iu
- J2505Injection, pegfilgrastim, 6 mg
- J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507Injection, pegloticase, 1 mg
- J2508Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2513Injection, pentastarch, 10% solution, 100 ml
- J2515Injection, pentobarbital sodium, per 50 mg
- J2516Injection, pentamidine isethionate, 1 mg
- J2540Injection, penicillin g potassium, up to 600,000 units
- J2543Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
- J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
- J2547Injection, peramivir, 1 mg
- J2550Injection, promethazine hcl, up to 50 mg
- J2560Injection, phenobarbital sodium, up to 120 mg
- J2561Injection, phenobarbital sodium (sezaby), 1 mg
- J2562Injection, plerixafor, 1 mg
- J2590Injection, oxytocin, up to 10 units
- J2596Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit
- J2597Injection, desmopressin acetate, per 1 mcg
- J2598Injection, vasopressin, 1 unit
- J2599Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit
- J2601Injection, vasopressin (baxter), 1 unit
- J2650Injection, prednisolone acetate, up to 1 ml
- J2670Injection, tolazoline hcl, up to 25 mg
- J2675Injection, progesterone, per 50 mg
- J2679Injection, fluphenazine hcl, 1.25 mg
- J2680Injection, fluphenazine decanoate, up to 25 mg
- J2690Injection, procainamide hcl, up to 1 gm
- J2700Injection, oxacillin sodium, up to 250 mg
- J2704Injection, propofol, 10 mg
- J2710Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720Injection, protamine sulfate, per 10 mg
- J2724Injection, protein c concentrate, intravenous, human, 10 iu
- J2725Injection, protirelin, per 250 mcg
- J2730Injection, pralidoxime chloride, up to 1 gm
- J2760Injection, phentolamine mesylate, up to 5 mg
- J2765Injection, metoclopramide hcl, up to 10 mg
- J2770Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777Injection, faricimab-svoa, 0.1 mg
- J2778Injection, ranibizumab, 0.1 mg
- J2779Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
- J2780Injection, ranitidine hydrochloride, 25 mg
- J2781Injection, pegcetacoplan, intravitreal, 1 mg
- J2782Injection, avacincaptad pegol, 0.1 mg
- J2783Injection, rasburicase, 0.5 mg
- J2785Injection, regadenoson, 0.1 mg
- J2786Injection, reslizumab, 1 mg
- J2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
- J2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
- J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
- J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
- J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
- J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
- J2793Injection, rilonacept, 1 mg
- J2794Injection, risperidone (risperdal consta), 0.5 mg
- J2795Injection, ropivacaine hydrochloride, 1 mg
- J2796Injection, romiplostim, 10 micrograms
- J2797Injection, rolapitant, 0.5 mg
- J2798Injection, risperidone, (perseris), 0.5 mg
- J2799Injection, risperidone (uzedy), 1 mg
- J2800Injection, methocarbamol, up to 10 ml
- J2801Injection, risperidone (rykindo), 0.5 mg
- J2802Injection, romiplostim, 1 microgram
- J2804Injection, rifampin, 1 mg
- J2805Injection, sincalide, 5 micrograms
- J2806Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
- J2810Injection, theophylline, per 40 mg
- J2820Injection, sargramostim (gm-csf), 50 mcg
- J2840Injection, sebelipase alfa, 1 mg
- J2850Injection, secretin, synthetic, human, 1 microgram
- J2860Injection, siltuximab, 10 mg
- J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
- J2910Injection, aurothioglucose, up to 50 mg
- J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919Injection, methylprednisolone sodium succinate, 5 mg
- J2920Injection, methylprednisolone sodium succinate, up to 40 mg
- J2930Injection, methylprednisolone sodium succinate, up to 125 mg
- J2940Injection, somatrem, 1 mg
- J2941Injection, somatropin, 1 mg
- J2950Injection, promazine hcl, up to 25 mg
- J2993Injection, reteplase, 18.1 mg
- J2995Injection, streptokinase, per 250,000 iu
- J2997Injection, alteplase recombinant, 1 mg
- J2998Injection, plasminogen, human-tvmh, 1 mg
- J3000Injection, streptomycin, up to 1 gm
- J3010Injection, fentanyl citrate, 0.1 mg
- J3030Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
- J3032Injection, eptinezumab-jjmr, 1 mg
- J3055Injection, talquetamab-tgvs, 0.25 mg
- J3060Injection, taliglucerase alfa, 10 units
- J3070Injection, pentazocine, 30 mg
- J3090Injection, tedizolid phosphate, 1 mg
- J3095Injection, telavancin, 10 mg
- J3101Injection, tenecteplase, 1 mg
- J3105Injection, terbutaline sulfate, up to 1 mg
- J3110Injection, teriparatide, 10 mcg
- J3111Injection, romosozumab-aqqg, 1 mg
- J3120Injection, testosterone enanthate, up to 100 mg
- J3121Injection, testosterone enanthate, 1 mg
- J3130Injection, testosterone enanthate, up to 200 mg
- J3140Injection, testosterone suspension, up to 50 mg
- J3145Injection, testosterone undecanoate, 1 mg
- J3150Injection, testosterone propionate, up to 100 mg
- J3230Injection, chlorpromazine hcl, up to 50 mg
- J3240Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241Injection, teprotumumab-trbw, 10 mg
- J3243Injection, tigecycline, 1 mg
- J3244Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245Injection, tildrakizumab, 1 mg
- J3246Injection, tirofiban hcl, 0.25 mg
- J3247Injection, secukinumab, intravenous, 1 mg
- J3250Injection, trimethobenzamide hcl, up to 200 mg
- J3260Injection, tobramycin sulfate, up to 80 mg
- J3262Injection, tocilizumab, 1 mg
- J3263Injection, toripalimab-tpzi, 1 mg
- J3265Injection, torsemide, 10 mg/ml
- J3268Injection, delafloxacin, 1 mg
- J3280Injection, thiethylperazine maleate, up to 10 mg
- J3285Injection, treprostinil, 1 mg
- J3290Injection, tranexamic acid, 5 mg
- J3291Injection, tranexamic acid in sodium chloride, 5 mg
- J3299Injection, triamcinolone acetonide (xipere), 1 mg
- J3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
- J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302Injection, triamcinolone diacetate, per 5 mg
- J3303Injection, triamcinolone hexacetonide, per 5 mg
- J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3305Injection, trimetrexate glucuronate, per 25 mg
- J3310Injection, perphenazine, up to 5 mg
- J3315Injection, triptorelin pamoate, 3.75 mg
- J3316Injection, triptorelin, extended-release, 3.75 mg
- J3320Injection, spectinomycin dihydrochloride, up to 2 gm
- J3350Injection, urea, up to 40 gm
- J3355Injection, urofollitropin, 75 iu
- J3357Ustekinumab, for subcutaneous injection, 1 mg
- J3358Ustekinumab, for intravenous injection, 1 mg
- J3360Injection, diazepam, up to 5 mg
- J3364Injection, urokinase, 5000 iu vial
- J3365Injection, iv, urokinase, 250,000 i.u. vial
- J3370Injection, vancomycin hcl, 500 mg
- J3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
- J3372Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg
- J3373Injection, vancomycin hydrochloride, 10 mg
- J3374Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
- J3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
- J3376Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
- J3379Injection, valproate sodium, 5 mg
- J3380Injection, vedolizumab, intravenous, 1 mg
- J3385Injection, velaglucerase alfa, 100 units
- J3386Injection, etuvetidigene autotemcel, per treatment
- J3387Injection, elivaldogene autotemcel, per treatment
- J3389Topical administration, prademagene zamikeracel, per treatment
- J3391Injection, atidarsagene autotemcel, per treatment
- J3392Injection, exagamglogene autotemcel, per treatment
- J3393Injection, betibeglogene autotemcel, per treatment
- J3394Injection, lovotibeglogene autotemcel, per treatment
- J3396Injection, verteporfin, 0.1 mg
- J3397Injection, vestronidase alfa-vjbk, 1 mg
- J3398Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
- J3399Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
- J3400Injection, triflupromazine hcl, up to 20 mg
- J3401Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- J3402Injection, remestemcel-l-rknd, per therapeutic dose
- J3403Revakinagene taroretcel-lwey, per implant
- J3404Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
- J3405Injection, onasemnogene abeparvovec-brve, per treatment
- J3406Injection, omidubicel-onlv, per therapeutic dose
- J3410Injection, hydroxyzine hcl, up to 25 mg
- J3411Injection, thiamine hcl, 100 mg
- J3415Injection, pyridoxine hcl, 100 mg
- J3420Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
- J3424Injection, hydroxocobalamin, intravenous, 25 mg
- J3425Injection, hydroxocobalamin, intramuscular, 10 mcg
- J3430Injection, phytonadione (vitamin k), per 1 mg
- J3465Injection, voriconazole, 10 mg
- J3470Injection, hyaluronidase, up to 150 units
- J3471Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)
- J3472Injection, hyaluronidase, ovine, preservative free, per 1000 usp units
- J3473Injection, hyaluronidase, recombinant, 1 usp unit
- J3475Injection, magnesium sulfate, per 500 mg
- J3480Injection, potassium chloride, per 2 meq
- J3485Injection, zidovudine, 10 mg
- J3486Injection, ziprasidone mesylate, 10 mg
- J3489Injection, zoledronic acid, 1 mg
- J3490Unclassified drugs
- J3520Edetate disodium, per 150 mg
- J3530Nasal vaccine inhalation
- J3535Drug administered through a metered dose inhaler
- J3570Laetrile, amygdalin, vitamin b17
- J3590Unclassified biologics
- J3591Unclassified drug or biological used for esrd on dialysis
- J7030Infusion, normal saline solution , 1000 cc
- J7040Infusion, normal saline solution, sterile (500 ml = 1 unit)
- J70425% dextrose/normal saline (500 ml = 1 unit)
- J7050Infusion, normal saline solution, 250 cc
- J70605% dextrose/water (500 ml = 1 unit)
- J7070Infusion, d5w, 1000 cc
- J7100Infusion, dextran 40, 500 ml
- J7110Infusion, dextran 75, 500 ml
- J7120Ringers lactate infusion, up to 1000 cc
- J71215% dextrose in lactated ringers infusion, up to 1000 cc
- J7131Hypertonic saline solution, 1 ml
- J7165Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
- J7168Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- J7169Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
- J7170Injection, emicizumab-kxwh, 0.5 mg
- J7171Injection, adamts13, recombinant-krhn, 10 iu
- J7172Injection, marstacimab-hncq, 0.5 mg
- J7173Injection, concizumab-mtci, 0.5 mg
- J7174Injection, fitusiran, 0.04 mg
- J7175Injection, factor x, (human), 1 i.u.
- J7176Injection, human fibrinogen - chmt (fesilty), 1 mg
- J7177Injection, human fibrinogen concentrate (fibryga), 1 mg
- J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
- J7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
- J7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.
- J7181Injection, factor xiii a-subunit, (recombinant), per iu
- J7182Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu
- J7183Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
- J7185Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
- J7186Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
- J7187Injection, von willebrand factor complex (humate-p), per iu vwf:rco
- J7188Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
- J7189Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
- J7190Factor viii (antihemophilic factor, human) per i.u.
- J7191Factor viii (antihemophilic factor (porcine)), per i.u.
- J7192Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
- J7193Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
- J7194Factor ix, complex, per i.u.
- J7195Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
- J7196Injection, antithrombin recombinant, 50 i.u.
- J7197Antithrombin iii (human), per i.u.
- J7198Anti-inhibitor, per i.u.
- J7199Hemophilia clotting factor, not otherwise classified
- J7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
- J7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
- J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
- J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
- J7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
- J7205Injection, factor viii fc fusion protein (recombinant), per iu
- J7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
- J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
- J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
- J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
- J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
- J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
- J7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
- J7214Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
- J7294Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
- J7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
- J7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
- J7297Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
- J7298Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
- J7299Intrauterine copper contraceptive (miudella)
- J7300Intrauterine copper contraceptive (paragard)
- J7301Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- J7303Contraceptive supply, hormone containing vaginal ring, each
- J7304Contraceptive supply, hormone containing patch, each
- J7306Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310Ganciclovir, 4.5 mg, long-acting implant
- J7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
- J7314Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
- J7315Mitomycin, ophthalmic, 0.2 mg
- J7316Injection, ocriplasmin, 0.125 mg
- J7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
- J7320Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
- J7321Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
- J7322Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg
- J7323Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
- J7324Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
- J7325Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
- J7326Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
- J7327Hyaluronan or derivative, monovisc, for intra-articular injection, per dose
- J7328Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
- J7329Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
- J7330Autologous cultured chondrocytes, implant
- J7331Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
- J7332Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
- J7333Hyaluronan or derivative, visco-3, for intra-articular injection, per dose
- J7335Capsaicin 8% patch, per 10 square centimeters
- J7336Capsaicin 8% patch, per square centimeter
- J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
- J7342Instillation, ciprofloxacin otic suspension, 6 mg
- J7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
- J7351Injection, bimatoprost, intracameral implant, 1 microgram
- J7352Afamelanotide implant, 1 mg
- J7353Anacaulase-bcdb, 8.8% gel, 1 gram
- J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- J7355Injection, travoprost, intracameral implant, 1 microgram
- J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
- J7401Mometasone furoate sinus implant, 10 micrograms
- J7402Mometasone furoate sinus implant, (sinuva), 10 micrograms
- J7500Azathioprine, oral, 50 mg
- J7501Azathioprine, parenteral, 100 mg
- J7502Cyclosporine, oral, 100 mg
- J7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505Muromonab-cd3, parenteral, 5 mg
- J7506Prednisone, oral, per 5 mg
- J7507Tacrolimus, immediate release, oral, 1 mg
- J7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509Methylprednisolone oral, per 4 mg
- J7510Prednisolone oral, per 5 mg
- J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512Prednisone, immediate release or delayed release, oral, 1 mg
- J7513Daclizumab, parenteral, 25 mg
- J7514Mycophenolate mofetil (myhibbin), oral suspension, 100 mg
- J7515Cyclosporine, oral, 25 mg
- J7516Injection, cyclosporine, 250 mg
- J7517Mycophenolate mofetil, oral, 250 mg
- J7518Mycophenolic acid, oral, 180 mg
- J7519Injection, mycophenolate mofetil, 10 mg
- J7520Sirolimus, oral, 1 mg
- J7521Tacrolimus, granules, oral suspension, 0.1 mg
- J7524Mycophenolate mofetil, oral, 5 mg
- J7525Tacrolimus, parenteral, 5 mg
- J7526Injection, mycophenolate mofetil, 5 mg
- J7527Everolimus, oral, 0.25 mg
- J7528Mycophenolate mofetil, for suspension, oral, 100 mg
- J7529Mycophenolate mofetil, for suspension, oral, 5 mg
- J7530Mycophenolate mofetil (myhibbin), oral suspension, 5 mg
- J7531Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
- J7599Immunosuppressive drug, not otherwise classified
- J7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
- J7620Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
- J7622Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7624Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
- J7627Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
- J7628Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7629Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7631Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7632Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7633Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
- J7634Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
- J7635Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7636Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7637Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7638Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
- J7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
- J7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7648Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7649Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7650Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7657Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7658Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7659Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7660Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7665Mannitol, administered through an inhaler, 5 mg
- J7667Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
- J7668Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
- J7669Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7670Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7674Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
- J7676Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
- J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
- J7680Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7681Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7682Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- J7683Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7684Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
- J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
- J7699Noc drugs, inhalation solution administered through dme
- J7799Noc drugs, other than inhalation drugs, administered through dme
- J7999Compounded drug, not otherwise classified
- J8498Antiemetic drug, rectal/suppository, not otherwise specified
- J8499Prescription drug, oral, non chemotherapeutic, nos
- J8501Aprepitant, oral, 5 mg
- J8502Injection, aprepitant (aponvie), 1 mg
- J8510Busulfan; oral, 2 mg
- J8515Cabergoline, oral, 0.25 mg
- J8520Capecitabine, oral, 150 mg
- J8521Capecitabine, oral, 500 mg
- J8522Capecitabine, oral, 50 mg
- J8530Cyclophosphamide; oral, 25 mg
- J8540Dexamethasone, oral, 0.25 mg
- J8541Dexamethasone (hemady), oral, 0.25 mg
- J8560Etoposide; oral, 50 mg
- J8562Fludarabine phosphate, oral, 10 mg
- J8565Gefitinib, oral, 250 mg
- J8597Antiemetic drug, oral, not otherwise specified
- J8600Melphalan; oral, 2 mg
- J8610Methotrexate; oral, 2.5 mg
- J8611Methotrexate (jylamvo), oral, 2.5 mg
- J8612Methotrexate (xatmep), oral, 2.5 mg
- J8650Nabilone, oral, 1 mg
- J8655Netupitant 300 mg and palonosetron 0.5 mg, oral
- J8670Rolapitant, oral, 1 mg
- J8700Temozolomide, oral, 5 mg
- J8705Topotecan, oral, 0.25 mg
- J8999Prescription drug, oral, chemotherapeutic, nos
- J9000Injection, doxorubicin hydrochloride, 10 mg
- J9003Leuprolide injectable (camcevi etm), 1 mg
- J9010Injection, alemtuzumab, 10 mg
- J9011Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015Injection, aldesleukin, per single use vial
- J9017Injection, arsenic trioxide, 1 mg
- J9019Injection, asparaginase (erwinaze), 1,000 iu
- J9020Injection, asparaginase, not otherwise specified, 10,000 units
- J9021Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022Injection, atezolizumab, 10 mg
- J9023Injection, avelumab, 10 mg
- J9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025Injection, azacitidine, 1 mg
- J9026Injection, tarlatamab-dlle, 1 mg
- J9027Injection, clofarabine, 1 mg
- J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- J9030Bcg live intravesical instillation, 1 mg
- J9031Bcg (intravesical) per instillation
- J9032Injection, belinostat, 10 mg
- J9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
- J9034Injection, bendamustine hcl (bendeka), 1 mg
- J9035Injection, bevacizumab, 10 mg
- J9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9037Injection, belantamab mafodotin-blmf, 0.5 mg
- J9038Injection, axatilimab-csfr, 0.1 mg
- J9039Injection, blinatumomab, 1 microgram
- J9040Injection, bleomycin sulfate, 15 units
- J9041Injection, bortezomib, 0.1 mg
- J9042Injection, brentuximab vedotin, 1 mg
- J9043Injection, cabazitaxel, 1 mg
- J9044Injection, bortezomib, not otherwise specified, 0.1 mg
- J9045Injection, carboplatin, 50 mg
- J9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
- J9047Injection, carfilzomib, 1 mg
- J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
- J9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
- J9050Injection, carmustine, 100 mg
- J9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
- J9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
- J9053Injection, belantamab mafodotin-blmf, 0.1 mg
- J9054Injection, bortezomib (boruzu), 0.1 mg
- J9055Injection, cetuximab, 10 mg
- J9056Injection, bendamustine hydrochloride (vivimusta), 1 mg
- J9057Injection, copanlisib, 1 mg
- J9058Injection, bendamustine hydrochloride (apotex), 1 mg
- J9059Injection, bendamustine hydrochloride (baxter), 1 mg
- J9060Injection, cisplatin, powder or solution, 10 mg
- J9061Injection, amivantamab-vmjw, 2 mg
- J9062Injection, amivantamab 5 mg and hyaluronidase-lpuj
- J9063Injection, mirvetuximab soravtansine-gynx, 1 mg
- J9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
- J9065Injection, cladribine, per 1 mg
- J9066Injection, bendamustine hydrochloride (avyxa), 1 mg
- J9070Cyclophosphamide, 100 mg
- J9071Injection, cyclophosphamide (auromedics), 5 mg
- J9072Injection, cyclophosphamide (frindovyx), 5 mg
- J9073Injection, cyclophosphamide (dr. reddy's), 5 mg
- J9074Injection, cyclophosphamide (sandoz), 5 mg
- J9075Injection, cyclophosphamide, not otherwise specified, 5 mg
- J9076Injection, cyclophosphamide (baxter), 5 mg
- J9098Injection, cytarabine liposome, 10 mg
- J9100Injection, cytarabine, 100 mg
- J9118Injection, calaspargase pegol-mknl, 10 units
- J9119Injection, cemiplimab-rwlc, 1 mg
- J9120Injection, dactinomycin, 0.5 mg
- J9130Dacarbazine, 100 mg
- J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145Injection, daratumumab, 10 mg
- J9150Injection, daunorubicin, 10 mg
- J9151Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155Injection, degarelix, 1 mg
- J9160Injection, denileukin diftitox, 300 micrograms
- J9161Injection, denileukin diftitox-cxdl, 1 mcg
- J9165Injection, diethylstilbestrol diphosphate, 250 mg
- J9171Injection, docetaxel, 1 mg
- J9172Injection, docetaxel (docivyx), 1 mg
- J9173Injection, durvalumab, 10 mg
- J9174Injection, docetaxel (beizray), 1 mg
- J9175Injection, elliotts' b solution, 1 ml
- J9176Injection, elotuzumab, 1 mg
- J9177Injection, enfortumab vedotin-ejfv, 0.25 mg
- J9178Injection, epirubicin hcl, 2 mg
- J9179Injection, eribulin mesylate, 0.1 mg
- J9181Injection, etoposide, 10 mg
- J9183Gemcitabine intravesical system, 225 mg
- J9184Injection, gemcitabine hydrochloride (avyxa), 200 mg
- J9185Injection, fludarabine phosphate, 50 mg
- J9186Injection, etoposide (avyxa), 1 mg
- J9187Injection, etoposide, 1 mg
- J9190Injection, fluorouracil, 500 mg
- J9191Injection, fluorouracil (avyxa), 10 mg
- J9192Injection, fluorouracil, 10 mg
- J9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
- J9198Injection, gemcitabine hydrochloride, (infugem), 100 mg
- J9199Injection, gemcitabine hydrochloride (infugem), 200 mg
- J9200Injection, floxuridine, 500 mg
- J9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202Goserelin acetate implant, per 3.6 mg
- J9203Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204Injection, mogamulizumab-kpkc, 1 mg
- J9205Injection, irinotecan liposome, 1 mg
- J9206Injection, irinotecan, 20 mg
- J9207Injection, ixabepilone, 1 mg
- J9208Injection, ifosfamide, 1 gram
- J9209Injection, mesna, 200 mg
- J9210Injection, emapalumab-lzsg, 1 mg
- J9211Injection, idarubicin hydrochloride, 5 mg
- J9212Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214Injection, interferon, alfa-2b, recombinant, 1 million units
- J9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
- J9216Injection, interferon, gamma 1-b, 3 million units
- J9217Leuprolide acetate (for depot suspension), 7.5 mg
- J9218Leuprolide acetate, per 1 mg
- J9219Leuprolide acetate implant, 65 mg
- J9220Injection, indigotindisulfonate sodium, 1 mg
- J9223Injection, lurbinectedin, 0.1 mg
- J9225Histrelin implant (vantas), 50 mg
- J9226Histrelin implant (supprelin la), 50 mg
- J9227Injection, isatuximab-irfc, 10 mg
- J9228Injection, ipilimumab, 1 mg
- J9229Injection, inotuzumab ozogamicin, 0.1 mg
- J9230Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
- J9232Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg
- J9245Injection, melphalan hydrochloride, not otherwise specified, 50 mg
- J9246Injection, melphalan (evomela), 1 mg
- J9247Injection, melphalan flufenamide, 1mg
- J9248Injection, melphalan (hepzato), 1 mg
- J9249Injection, melphalan (apotex), 1 mg
- J9250Methotrexate sodium, 5 mg
- J9255Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
- J9256Injection, nipocalimab-aahu, 3 mg
- J9258Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
- J9259Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg
- J9260Injection, methotrexate sodium, 50 mg
- J9261Injection, nelarabine, 50 mg
- J9262Injection, omacetaxine mepesuccinate, 0.01 mg
- J9263Injection, oxaliplatin, 0.5 mg
- J9264Injection, paclitaxel protein-bound particles, 1 mg
- J9265Injection, paclitaxel, 30 mg
- J9266Injection, pegaspargase, per single dose vial
- J9267Injection, paclitaxel, 1 mg
- J9268Injection, pentostatin, 10 mg
- J9269Injection, tagraxofusp-erzs, 10 micrograms
- J9270Injection, plicamycin, 2.5 mg
- J9271Injection, pembrolizumab, 1 mg
- J9272Injection, dostarlimab-gxly, 10 mg
- J9273Injection, tisotumab vedotin-tftv, 1 mg
- J9274Injection, tebentafusp-tebn, 1 microgram
- J9275Injection, cosibelimab-ipdl, 2 mg
- J9276Injection, zanidatamab-hrii, 2 mg
- J9277Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
- J9278Injection, carboplatin (avyxa), 1 mg
- J9280Injection, mitomycin, 5 mg
- J9281Mitomycin pyelocalyceal instillation, 1 mg
- J9282Mitomycin, intravesical instillation, 1 mg
- J9285Injection, olaratumab, 10 mg
- J9286Injection, glofitamab-gxbm, 2.5 mg
- J9289Injection, nivolumab, 2 mg and hyaluronidase-nvhy
- J9292Injection, pemetrexed dipotassium, 10 mg
- J9293Injection, mitoxantrone hydrochloride, per 5 mg
- J9294Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
- J9295Injection, necitumumab, 1 mg
- J9296Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
- J9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
- J9298Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
- J9299Injection, nivolumab, 1 mg
- J9300Injection, gemtuzumab ozogamicin, 5 mg
- J9301Injection, obinutuzumab, 10 mg
- J9302Injection, ofatumumab, 10 mg
- J9303Injection, panitumumab, 10 mg
- J9304Injection, pemetrexed (pemfexy), 10 mg
- J9305Injection, pemetrexed, not otherwise specified, 10 mg
- J9306Injection, pertuzumab, 1 mg
- J9307Injection, pralatrexate, 1 mg
- J9308Injection, ramucirumab, 5 mg
- J9309Injection, polatuzumab vedotin-piiq, 1 mg
- J9310Injection, rituximab, 100 mg
- J9311Injection, rituximab 10 mg and hyaluronidase
- J9312Injection, rituximab, 10 mg
- J9313Injection, moxetumomab pasudotox-tdfk, 0.01 mg
- J9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg
- J9315Injection, romidepsin, 1 mg
- J9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
- J9317Injection, sacituzumab govitecan-hziy, 2.5 mg
- J9318Injection, romidepsin, non-lyophilized, 0.1 mg
- J9319Injection, romidepsin, lyophilized, 0.1 mg
- J9320Injection, streptozocin, 1 gram
- J9321Injection, epcoritamab-bysp, 0.16 mg
- J9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
- J9323Injection, pemetrexed ditromethamine, 10 mg
- J9324Injection, pemetrexed (pemrydi rtu), 10 mg
- J9325Injection, talimogene laherparepvec, per 1 million plaque forming units
- J9326Injection, telisotuzumab vedotin-tllv, 1 mg
- J9328Injection, temozolomide, 1 mg
- J9329Injection, tislelizumab-jsgr, 1mg
- J9330Injection, temsirolimus, 1 mg
- J9331Injection, sirolimus protein-bound particles, 1 mg
- J9332Injection, efgartigimod alfa-fcab, 2mg
- J9333Injection, rozanolixizumab-noli, 1 mg
- J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9340Injection, thiotepa, 15 mg
- J9341Injection, thiotepa (tepylute), 1 mg
- J9342Injection, thiotepa, not otherwise specified, 1 mg
- J9345Injection, retifanlimab-dlwr, 1 mg
- J9347Injection, tremelimumab-actl, 1 mg
- J9348Injection, naxitamab-gqgk, 1 mg
- J9349Injection, tafasitamab-cxix, 2 mg
- J9350Injection, mosunetuzumab-axgb, 1 mg
- J9351Injection, topotecan, 0.1 mg
- J9352Injection, trabectedin, 0.1 mg
- J9353Injection, margetuximab-cmkb, 5 mg
- J9354Injection, ado-trastuzumab emtansine, 1 mg
- J9355Injection, trastuzumab, excludes biosimilar, 10 mg
- J9356Injection, trastuzumab, 10 mg and hyaluronidase-oysk
- J9357Injection, valrubicin, intravesical, 200 mg
- J9358Injection, fam-trastuzumab deruxtecan-nxki, 1 mg
- J9359Injection, loncastuximab tesirine-lpyl, 0.075 mg
- J9360Injection, vinblastine sulfate, 1 mg
- J9361Injection, efbemalenograstim alfa-vuxw, 0.5 mg
- J9362Injection, trabectedin, 0.01 mg
- J9370Vincristine sulfate, 1 mg
- J9371Injection, vincristine sulfate liposome, 1 mg
- J9376Injection, pozelimab-bbfg, 1 mg
- J9380Injection, teclistamab-cqyv, 0.5 mg
- J9381Injection, teplizumab-mzwv, 5 mcg
- J9382Injection, zenocutuzumab-zbco, 1 mg
- J9390Injection, vinorelbine tartrate, 10 mg
- J9393Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
- J9394Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
- J9395Injection, fulvestrant, 25 mg
- J9400Injection, ziv-aflibercept, 1 mg
- J9600Injection, porfimer sodium, 75 mg
- J9601Injection, linvoseltamab-gcpt, 1 mg
- J9999Not otherwise classified, antineoplastic drugs